The Harderian glands are innervated by sympathetic fibers originating in the superior cervical ganglia. The aim of this study is to characterize the /3-adrenergic receptors in the rat Harderian gland. The characteristics of/3-adrenergic receptors were determined in crude membrane preparations from rat Binding values are low during the daytime and increase progressively late in the evening to reach a maximum at 2200 h (2 h after the onset of dark period), but decreased to the end of the dark period (0600 h). In conclusion, the results presented in this paper show the functional and pharmacological characterization of/3-adrenergic receptors in the rat Harderian gland. This neurotransmitter may play a physiological role at this level regulating, at least, processes such as a thyroid hormone metabolism.
INTRODUCTION
Harderian glands were discovered by Harder in 1694, and are found in the medial and posterior area to the eyeball. The Harderian glands are large tubuloalveolar, possessing a nictating membrane (Davis, 1929) . In the hamster, but not in the rat, Harderian glands exhibit marked sexual differences; the female type possesses a single type of secretory cells (type I), while the male type gland exhibits two secretory cell types (type I and type II) which appear in similar percentage (50%) (Hoffman, 1971) . Type II cells are exclusively present in the male hamster but disappear after androgen deprivation being replaced by type I cells that express melatonin receptors (Menendez-Pelaez et al., 1993) . Characteristically, the Harderian glands of many species contain several indoleamines, melatonin (Menendez-Pelaez et al., 1989) , and porphyrins (Margolis, 1971) , showing marked sexual differences, with male levels being much lower than those of female. The castration can cause substantial changes in the porphyrin concentrations in the Harderian glands of the male hamster. Likewise, light deprivation for as short a period as 1 week by means of bilateral enucleation led to significant reduction in the porphyrin concentration in the Harderian glands of female hamsters ('Van Jaarsveld et al., 1989) .
In addition, several rhythms that may be related to the light:dark cycle have been described in the Harderian gland, such as melatonin content (Reiter et al., 1983) and specific melatonin receptors Calvo et al., 1995) . Harderian glands also contain the deiodinating enzyme, type II thyroxine 5'deiodinase (Guerrero et al., 1987) . Presumably, darkness induces increases in the enzyme activity by releasing norepinephrine from the postganglionic nerve endings that innervate the Harderian gland (Osuna et al., 1992) . The Harderian glands are innervated by sympathetic fibers originating in the superior cervical ganglia (Huhtala et al., 1977) . In rat and other mammalian species studied, Harderian glands not only contain adrenergic and cholinergic nerve fibers, but also a considerable number of VIP immunoreactive nerve fibers localized close to the acini and surrounding blood vessels (Tsukahara and Jacobowitz, 1987) . Finally, the Syrian hamster Harderian gland also contains fl-adrenoceptors, which exhibit pronounced sexual differences. Both the receptor number and the dissociation constant are higher in females than in males (Pangerl et al., 1989a) .
The aim of this study is to characterize the/3-adrenergic receptors in the rat Harderian gland. We show that [125I]iodocyanopindolol, a/3-adrenergic receptor antagonist, is specifically bound by Harderian gland crude membranes, exhibiting day-night variations with maximal binding early in the dark period.
MATERIALS AND METHODS

Materials
Bacitracin, bovine serum albumin (BSA), ethylenediaminetetraacetic acid (EDTA), N-[2-hydroxyethyl]piperazine-N-[2-hydroxypropanesulfonic acid] (HEPES), isoproterenol, propanolol, clonidine, yohimbine, methoxamine, and prazosin were purchased from Sigma Chemical Company (St. Louis, MO, USA). Phenylmethylsulfonylfluoride (PMSF), N-a-tosyl-L-lysine chloromethyl ketone (TLCK), and leupeptin were from Boehringer Mannheim GmbH (Germany).
[125I]iodocyanopindolol ([125I]CYP; 2200 Ci/mmol) was from Amershaml (Amersham, UK). 
Animals and Membrane Preparation
Adult male Wistar rats born in our animal facility were used. Animals received food and water ad libitum and were exposed to an automatically regulated light:dark (LD) cycle of 14:10; the lights were turned off daily from 2000 through 0600 h. On the day of the experiment, animals were killed by decapitation and Harderian glands were quickly collected, frozen on solid CO2, and stored at -80~ until assayed.
For membrane preparation, the glands were homogenized using a Polytron (2 • I min) in 10 mM Tris-CH1 buffer, pH 7.5, containing 0.25 M sucrose, 0.5 mM EDTA, 0.1mg/ml bacitracin, 0.01mg/ml TLCK, 0.01mg/ml leupeptin, and 0.05 mg/ml PMSF. The homogenate was centrifuged at 16,000 rpm for 30 min at 4~ The pellet (crude membranes) was washed twice in 20 mM Hepes, pH 7.5, and the final pellet was immediately frozen at -80~ until used. Protein concentration was determined by using BSA as standard (Lowry et al., 1951) .
Binding of [1251]CYP to Membranes
For binding reaction, the incubation medium (final volume 0.4 ml) contained 200/.d of crude membranes, 100/~1 of [125I]CYP and, when required, 100/~1 of displacing ligand. For saturation binding studies we used concentrations of radioligand between 3 and 1200pM. The incubation was stopped by adding 10 mM Tris buffer, pH 7.6, (containing 154 mM NaCI, 1 mM MgCI2, and 1 mM ascorbic acid), and centrifuged. Then, the radioactivity of the pellet was counted in a Beckman gamma-counter. Specific binding was defined as the total binding minus the binding measured in the presence of 1/~M of propranolol. The equilibrium dissociation constant (Ka) and the maximal number of binding sites (Bmax) was calculated from plots according to Scatchard (1949) . Data were statistically analyzed using an ANOVA, followed by a Student-Newman-Keuls multiple range T test.
RESULTS
The specific binding of [~25I]CYP to rat Harderian gland membranes was a time and temperature-dependent process (Fig. 1) . At 30~ the binding of [125I]CYP to membranes was rapid, with maximal values at 30 rain and was stable until 90 rain. At 0 and 20~ an apparent equilibrium was achieved between 60 and 90 min, but the maximal binding observed was lesser than that obtained at 30~ Therefore, it was decided to undertake all subsequent experiments for 30 min at 30~
To determine whether the binding of [125I]CYP was a process dependent on the membrane protein concentration, the specific binding of [I~I]CYP was studied in the presence of increasing membrane protein concentrations. Figure 2 shows that binding of [125I]CYP was linearly related to membrane protein concentration, at least up to 300~g/ml (r = 0.995). Further incubations were performed with 300/zg membrane protein/ml, at 30~ for 30min to provide maximal binding. Under optimal conditions binding of [125I]CYP to rat Harderian gland membranes increased during the first 30 min and equilibrated after approximately 30-60min (Fig. 3, top) , with K § = 1.62. 109M -1 min -1 (Fig. 3, left bottom) . Following equilibrium, binding of [t25I]CYP to Harderian gland membranes was reversible. Dissociation of the tracer-membrane complex was studied by the addition of 1/xM of propranolol; this test indicated a half-time of dissociation of about 10min, with K-1 =0.086min -1 (Fig. 3, right bottom) . The kinetically derived value of Ko = 52.0 pM, was obtained from the ratio of the rate constants (k-1/k § Stoichiometric studies showed that binding of [125I]CYP to rat Harderian gland membranes increased with increasing concentrations of radioligand at 1.2 nM (Fig. 4) . Scatchard analysis of the data (Fig. 4, inset) shows binding to a [125I]CYP (50pM) was incubated with crude membranes (300/zg/ml) at 30~ at the times indicated. After 30rnin incubation, 10/xM propranolol was added and the specifically bound radioactivity was determined at the appropriated times, and expressed as the percentage of radioactivity at time zero. Leftbottom: Pseudo-first order plot of the association data 9
Bm~ is the specific binding at equilibrium. B is the Half-maximal inhibition (ICs0) was observed at about 28.1 nM. The specificity of /3-adrenoceptors in Harderian gland membranes was also investigated by determining the ability of various compounds to compete with the binding of [lzsI]CYP. The order of potency of these compounds, as expressed by the IC50 value, was as follows: isoproterenol (19.1nM), propranolol (28.1nM), and norepinephrine (96.3nM). Clonidine, yohimbine, methoxamine, and prazosin were ineffective at concentration up to 1/xM (Fig. 6) . Thus, binding of [125I]CYP to Harderian gland membrane was specific for fl-adrenergic agonists or blockers as indicated by the fact that only isoproterenol, propranolol, and nonrepinephrine were able to inhibit the binding of the tracer to the membranes. Binding [125I]CYP by Harderian gland membranes exhibited day-night variations ( Fig. 7) . Binding values were low during the daytime and increased progressively late in the evening to reach a maximum at 2200h; then, binding decreased at the end of the dark period (0600 h).
DISCUSSION
In the present paper we show that [lzSI]CYP, a ~-adrenergic receptor ligand, may interact with rat Harderian gland crude membranes through high-affinity binding sites. Binding of [125I]CYP by membranes fulfills all criteria for binding to a receptor site. Thus, binding exhibits properties such as dependence on time and temperature as well as reversibility, saturability, high affinity, and specificity. The Kd computed from the kinetic analysis agreed to that derived from the saturation study, suggesting that the binding followed mass action principles for a pseudo first order reaction. Saturation studies were performed using exclusively increasing concentrations of [lZsI]CYP. Interpretation of the data by the Scatchard analysis (Scatchard, 1949) are in the same range of those obtained in the Syrian hamster Harderian gland (Pangerl et al., 1989a) , and in the pineal gland of rat (Gonzalez-Brito et al., 1988) and hamster (Pangerl et al., 1989b (Pangerl et al., , 1990 ; they were also similar to values reported using different ligands in other tissues (Dax et aL, 1986; Neve et al., 1986) . With respect to specificity, the greater affinity of the/3-adrenergic agonists and blockers compared with other adrenergic agonists has been previously demonstrated with different ligands and tissues. In this study, binding of [125I]CYP to rat Harderian gland membranes exhibited diurnal variations with peak values early in the dark period, and low values late at night and during the day. Although stoichiometric studies remain to be performed during the day:night cycle, previous results suggest that these changes in the binding of [IZsI] CYP to membranes are associated to changes in the binding capacity rather than to changes in the affinity of the receptor (Pangerl et al., 1989a) . Our results agree with previous investigations that a diurnal rhythm exists in the binding capacity of [I2SI]CYP in the hamster Harderian gland (Pangerl et aL, 1989a) , and in the pineal gland of the hamster (Pangerl et aL, 1989b) or the rat (Gonzalez-Brito et al., 1988) .
The physiological role of/3-adrenergic receptor in the rat Harderian gland is not well established. However, evidence has been accumulated indicating that adrenergic agonists activate the enzyme, type II thyroxine 5'-deiodinase. This enzyme has been found in the Harderian gland of rat (Guerrero et al., 1987) and hamster where it is believed to have an important role in maintaining intracellular levels of T3 and to serve as a defense against thyroid hormone deficiency. Its activity is regulated, not only by the thyroid status, but also by both a-and/3-adrenergic agonists (Osuna et al., 1990 (Osuna et al., , 1992 Rubio et aL, 1991) .
In conclusion, the results presented in this paper show the functional and pharmacological characterization of/3-adrenergic receptors in the rat Harderian gland. This neurotransmitter may play a physiological role at this level regulating, at least, processes such as a thyroid hormone metabolism.
